Clinical trial NCT05959980: Cervical Fixation Surgery Cervical Collar for Management of Hirayama Disease: A Randomized Study
Official title: Posterior Cervical Fixation Versus Long-term Cervical Collar for Management of Hirayama Disease: Prospective Randomized Open Blinded Endpoint (PROBE), Phase III Study
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Hirayama Disease
Keywords: Hirayama disease
cervical collar
posterior cervical fixation surgery
Lead sponsor: All India Institute of Medical Sciences
Sponsor class: OTHER
First posted: 2023-07-25
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The goal of this clinical trial\] is to compare cervical collar versus neck stabilization surgery in diagnosed patients of Hirayama disease who have been reporting worsening of problems in the past six months. The main question\[s\] it aims to answer are:

• Is cervical stabilization surgery (Posterior cervical fixation) superior to conservative management in the form of cervical collar placement in patients with progressive Hirayama disease, observed at six months after intervention

Participants will have equal chance to:

* Undergo cervical fixation surgery
* Cervical collar management The investigators will study and compare the efficacy of both treatments upto six months after intervention

Detailed description: 1. Study design:

   Prospective randomized open blinded endpoint (PROBE), phase III study
2. Inclusion criteria:

All the following:

1. Age ≥ 18 years
2. Patients with Hirayama disease as per the following criteria (All of the following) (16):

   1. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)
   2. Progressive course, or initial progression followed by stationary course; and
   3. No evidence of a compressive lesion of the spinal cord.
3. Disease duration of ≤4 years
4. Progression of clinical symptoms in the past six-months c. Exclusion criteria:

Any of the following:

1) Refusal to consent for randomization 2) Not willing to come for three- and six-months follow-up e. Procedures at baseline:

1. Clinical, electrophysiology and autonomic function assessments:

   After the clinical diagnosis by inclusion criteria, the patients will undergo a detailed clinical examination (as per the case record form (CRF), which includes power, autonomic features, grip strength), and the objective assessment of the electrophysiological parameters
2. Radiological assessment:

   All patients will undergo MR imaging on a 1.5 T MR scanner (Optima 450w, General Electric, Milwaukee, USA), using an 8-channel cervical-thoracic-lumbar array spine coil. The imaging will include axial and sagittal T2-WIs and post-gadolinium T1+C in flexion, neutral and extension positions. In addition, DTI protocol will include sagittal and axial acquisition of cervical cord in neutral position. MR-DTI data will process on a dedicated workstation (Advantage Windows workstation, GE Healthcare, WI, USA) using commercially available software (Functool 14.3.01, GE HealthCare, WI, USA). After co-registration of raw images to correct the motion and distortion artefacts, the ADC and FA images will be generated. The mean, minimum and maximum values of FA and ADC will be recorded from region of maximum cord compression/ T2-hyperintensity.

   The investogators will get a cervical spine radiograph at the time of discharge and at 6 months.
3. Surgical procedure:

The patients who are randomized to undergo posterior cervical fixation will be admitted in Neurosciences Centre, All India Institute of Medical Sciences, New Delhi. These patients will undergo routine preoperative work up, including routine blood investigations and a detailed preanesthetic checkup (PAC). These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.

Eligibility criteria: Inclusion Criteria:

* All the following:

  1. Age ≥ 18 years
  2. Patients with Hirayama disease as per the following criteria (All of the following) (16):

     1. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)
     2. Progressive course, or initial progression followed by stationary course; and
     3. No evidence of a compressive lesion of the spinal cord.
  3. Disease duration of ≤4 years
  4. Progression of clinical symptoms in the past six-months

Exclusion Criteria:

* Any of the following:

  1. Refusal to consent for randomization
  2. Not willing to come for three- and six-months follow-up

Primary outcomes:
measure: Odom's criteria score at six months
timeFrame: Six months after intervention
Secondary outcomes:
measure: Odom's criteria score at three months
timeFrame: Three months after intervention
measure: interval change in DTI metrics of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) of cervical cord
timeFrame: at six-months post-intervention
measure: Electrophysiological and grip strength
timeFrame: 6 month
Other outcomes:
Locations:
city: New Delhi
country: India
facility: Deepti Vibha
state: Delhi
Study officials:
affiliation: AIIMS, New Delhi
name: Deepti Vibha
role: PRINCIPAL_INVESTIGATOR
References: